Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy-Reference-Cited by-同舟云学术

Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy

Published:2011-01-28 Issue:6 Volume:67 Page:1465-1469
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Masuda Takeshi,Hattori Noboru,Hamada Akinobu,Iwamoto Hiroshi,Ohshimo Shinichiro,Kanehara Masashi,Ishikawa Nobuhisa,Fujitaka Kazunori,Haruta Yoshinori,Murai Hiroshi,Kohno Nobuoki

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-011-1555-6.pdf

Reference23 articles.

1. Taillibert S, Laigle-Donadey F, Chodkiewicz C, Sanson M, Hoang-Xuan K, Delattre JY (2005) Leptomeningeal metastases from solid malignancy: a review. J Neurooncol 75:85–99

2. Grossman SA, Krabak MJ (1999) Leptomeningeal carcinomatosis. Cancer Treat Rev 25:103–119

3. Ceresoli GL, Reni M, Chiesa G, Carretta A, Schipani S, Passoni P, Bolognesi A, Zannini P, Villa E (2002) Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis. Cancer 95:605–612

4. O’Meara WP, Borkar SA, Stambuk HE, Lymberis SC (2007) Leptomeningeal metastasis. Curr Probl Cancer 31:367–424

5. Chamberlain MC, Kormanik P (1998) Carcinoma meningitis secondary to non-small cell lung cancer: combined modality therapy. Arch Neurol 55:506–512

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysis;Heliyon;2024-05

2. Osimertinib Improves overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastases;Translational Oncology;2023-05

3. Therapeutic Monitoring of Orally Administered, Small-Molecule Anticancer Medications with Tumor-Specific Cellular Protein Targets in Peripheral Fluid Spaces—A Review;Pharmaceutics;2023-01-10

4. Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer;Frontiers in Oncology;2022-11-15

5. Leptomeningeal Metastatic L858R EGFR-mutant Lung Cancer: Prompt Response to Osimertinib in the Absence of T790M-mutation and Effective Subsequent Pulsed Erlotinib;OncoTargets and Therapy;2022-06